Potassium Ion

Potassium Ion

SCHEMBL4053333

[K+].c1cnn([BH-](n2cccn2)n2cccn2)c1

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.32
FBP1 P09467 1/20 0.31
KDM4E B2RXH2 2/20 0.30
ALDH1A1 P00352 2/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
G6PD P11413 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535027 0.97 NOS1 (0.33) NOS1FBP1KDM4EALDH1A1MEN1
SCHEMBL14995903 0.94 NOS1 (0.32) NOS1FBP1KDM4EALDH1A1MEN1
Zinc Ion SCHEMBL14995218 0.94 NOS1 (0.32) NOS1FBP1KDM4EALDH1A1MEN1
SCHEMBL3897072 0.94 NOS1 (0.32) NOS1FBP1KDM4EALDH1A1MEN1
SCHEMBL21840160 0.94 NOS1 (0.32) NOS1FBP1KDM4EALDH1A1MEN1
SCHEMBL14993888 0.94 NOS1 (0.32) NOS1FBP1KDM4EALDH1A1MEN1
Lithium Ion SCHEMBL4055341 0.94 NOS1 (0.32) NOS1FBP1KDM4EALDH1A1MEN1
SCHEMBL10607798 0.89 NOS1 (0.30) NOS1
SCHEMBL8740897 0.63
SCHEMBL23791199 0.61 NOS1 (0.33) NOS1FBP1KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119650923-A Method for regenerating lithium iron phosphate positive electrode material by wet grinding, positive electrode plate and battery 威尔能环保科技(苏州)有限公司 2025-03-18 CN claimed
CN-119361888-A Method for regenerating lithium iron phosphate positive electrode material by liquid phase, positive electrode plate and battery 威尔能环保科技(苏州)有限公司 2025-01-24 CN claimed
US-20240228912-A9 COMPOSITION FOR CLEANING SEMICONDUCTOR SUBSTRATE, AND CLEANING METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-07-11 US claimed
US-20240132805-A1 COMPOSITION FOR CLEANING SEMICONDUCTOR SUBSTRATE, AND CLEANING METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-04-25 US claimed
EP-4307348-A1 COMPOSITION FOR CLEANING SEMICONDUCTOR SUBSTRATE, AND CLEANING METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-01-17 EP claimed
CN-117015845-A Composition for cleaning semiconductor substrate and cleaning method 三菱瓦斯化学株式会社 2023-11-07 CN claimed
WO-2022191051-A1 COMPOSITION FOR CLEANING SEMICONDUCTOR SUBSTRATE, AND CLEANING METHOD 三菱瓦斯化学株式会社 2022-09-15 WO claimed
US-11071750-B2 Soluble adducts of boric acid or derivatives and precursors thereof with chitosan oligosaccharide derivatives BIOPOLIFE SRL (IT) 2021-07-27 US claimed
US-20200113929-A1 SOLUBLE ADDUCTS OF BORIC ACID OR DERIVATIVES AND PRECURSORS THEREOF WITH CHITOSAN OLIGOSACCHARIDE DERIVATIVES BIOPOLIFE SRL (75% ownership) (IT) 2020-04-16 US claimed
US-9840522-B2 Multi-modal bioprobe for bladder cancer imaging and photodynamic therapy HONG KONG BAPTIST UNIVERSITY (HK) 2017-12-12 US claimed
US-20170107238-A1 MULTI-MODAL BIOPROBE FOR BLADDER CANCER IMAGING AND PHOTODYNAMIC THERAPY HONG KONG BAPTIST UNIVERSITY (HK) 2017-04-20 US claimed
CN-119855838-A Process for conjugation of hyaluronic acid and conjugates of hyaluronic acid thus obtained 格里克科尔制药有限责任公司 2025-04-18 CN disclosed
CN-119650923-A Method for regenerating lithium iron phosphate positive electrode material by wet grinding, positive electrode plate and battery 威尔能环保科技(苏州)有限公司 2025-03-18 CN disclosed
CN-119361888-A Method for regenerating lithium iron phosphate positive electrode material by liquid phase, positive electrode plate and battery 威尔能环保科技(苏州)有限公司 2025-01-24 CN disclosed
US-20240228912-A9 COMPOSITION FOR CLEANING SEMICONDUCTOR SUBSTRATE, AND CLEANING METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-07-11 US disclosed
US-6652608-B1 Fuel compositions exhibiting improved fuel stability OCTANE INTERNATIONAL, LTD. 2003-11-25 US disclosed
EP-1051461-A2 FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE ORR, William C. (US) 2000-11-15 EP disclosed
WO-1999066009-A2 FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE ORR WILLIAM C (US) 1999-12-23 WO disclosed
EP-0954558-A1 FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY ORR, William C. (US) 1999-11-10 EP disclosed
WO-1998026028-A1 FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY ORR WILLIAM C (US) 1998-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170107238-A1 MULTI-MODAL BIOPROBE FOR BLADDER CANCER IMAGING AND PHOTODYNAMIC THERAPY ITGB3, ITGB5, ITGB2 NOS1 1774/4885FBP1 2412/4885KDM4E 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.